Personalized Medicine in Infectious Diseases
This special issue belongs to the section "Personalized Therapy and Drug Delivery".
Special Issue Information
Dear Colleagues,
This Special Issue entitled "Personalized Medicine in Infectious Diseases" explores the evolving field of personalized medicine within the context of infectious diseases. It begins by providing a background and history of how personalized medicine has developed, particularly in addressing infectious diseases.
The aim and scope of this Special Issue encompass the application of personalized medicine in infectious diseases.
It highlights cutting-edge research that is transforming the treatment and management of infectious diseases through personalized approaches. We are particularly interested in research conducted using new methodological approaches and techniques as well as bioinformatics tools, including big data analysis.
We welcome original research or review articles pertaining to, but not limited to, the interplay of host and viral factors in the following topics:
- Genetic predisposition to infectious diseases;
- Post-acute infection syndromes (e.g., long-COVID symptoms and severity);
- Response, potential adverse events, and duration of protection of vaccines;
- Response to therapy and development of resistance.
Prof. Dr. Cleo Anastassopoulou
Prof. Dr. George P. Patrinos
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- infectious diseases
- genetic predisposition
- post-acute infection syndromes
- long-COVID
- response, potential adverse events, and duration of protection of vaccines
- response to therapy and development of resistance
- personalized medicine
- precision diagnostics
- treatment strategies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Published Papers
J. Pers. Med. - ISSN 2075-4426